Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Task-evoked Pupillometry in AD, MCI, and Depression-Related Cognitive Impairment

NCT07402356 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT07402356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Task-evoked Pupillometry in AD, MCI, and Depression-Related Cognitive Impairment
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer s disease, dementia, major depressive disorder (mdd), mild cognitive impairment